nodes	percent_of_prediction	percent_of_DWPC	metapath
Etoposide—Topoisomerase Inhibitors—Mitoxantrone—multiple sclerosis	0.652	1	CiPCiCtD
Etoposide—TOP2A—Mitoxantrone—multiple sclerosis	0.0315	0.125	CbGbCtD
Etoposide—ABCC10—Methotrexate—multiple sclerosis	0.0188	0.0746	CbGbCtD
Etoposide—CYP2E1—Fingolimod—multiple sclerosis	0.0177	0.0701	CbGbCtD
Etoposide—ABCC1—Mitoxantrone—multiple sclerosis	0.0174	0.0691	CbGbCtD
Etoposide—ABCG2—Cladribine—multiple sclerosis	0.016	0.0634	CbGbCtD
Etoposide—PTGS2—Triamcinolone—multiple sclerosis	0.0133	0.0525	CbGbCtD
Etoposide—ABCC3—Methotrexate—multiple sclerosis	0.0118	0.0469	CbGbCtD
Etoposide—ABCG2—Mitoxantrone—multiple sclerosis	0.0117	0.0463	CbGbCtD
Etoposide—PTGS2—Betamethasone—multiple sclerosis	0.0114	0.0451	CbGbCtD
Etoposide—CYP2E1—Mitoxantrone—multiple sclerosis	0.00832	0.033	CbGbCtD
Etoposide—ABCC1—Methotrexate—multiple sclerosis	0.00727	0.0288	CbGbCtD
Etoposide—ABCC2—Dexamethasone—multiple sclerosis	0.00669	0.0265	CbGbCtD
Etoposide—PTGS2—Dexamethasone—multiple sclerosis	0.00662	0.0262	CbGbCtD
Etoposide—ABCG2—Dexamethasone—multiple sclerosis	0.00605	0.024	CbGbCtD
Etoposide—ABCB1—Methylprednisolone—multiple sclerosis	0.00577	0.0229	CbGbCtD
Etoposide—ABCC2—Methotrexate—multiple sclerosis	0.00538	0.0213	CbGbCtD
Etoposide—CYP3A4—Fingolimod—multiple sclerosis	0.00536	0.0213	CbGbCtD
Etoposide—ABCG2—Methotrexate—multiple sclerosis	0.00486	0.0193	CbGbCtD
Etoposide—CYP2E1—Dexamethasone—multiple sclerosis	0.00431	0.0171	CbGbCtD
Etoposide—ABCB1—Mitoxantrone—multiple sclerosis	0.00421	0.0167	CbGbCtD
Etoposide—ABCB1—Betamethasone—multiple sclerosis	0.00375	0.0149	CbGbCtD
Etoposide—ABCB1—Prednisolone—multiple sclerosis	0.0037	0.0147	CbGbCtD
Etoposide—ABCB1—Prednisone—multiple sclerosis	0.0035	0.0139	CbGbCtD
Etoposide—CYP3A4—Methylprednisolone—multiple sclerosis	0.00346	0.0137	CbGbCtD
Etoposide—CYP3A5—Dexamethasone—multiple sclerosis	0.00335	0.0133	CbGbCtD
Etoposide—CYP2C8—Dexamethasone—multiple sclerosis	0.00322	0.0128	CbGbCtD
Etoposide—CYP3A4—Triamcinolone—multiple sclerosis	0.00262	0.0104	CbGbCtD
Etoposide—CYP3A4—Mitoxantrone—multiple sclerosis	0.00252	0.00999	CbGbCtD
Etoposide—CYP3A4—Betamethasone—multiple sclerosis	0.00225	0.00891	CbGbCtD
Etoposide—CYP3A4—Prednisolone—multiple sclerosis	0.00222	0.00879	CbGbCtD
Etoposide—ABCB1—Dexamethasone—multiple sclerosis	0.00218	0.00865	CbGbCtD
Etoposide—CYP3A4—Prednisone—multiple sclerosis	0.00209	0.0083	CbGbCtD
Etoposide—ABCB1—Methotrexate—multiple sclerosis	0.00175	0.00695	CbGbCtD
Etoposide—CYP3A4—Dexamethasone—multiple sclerosis	0.00131	0.00518	CbGbCtD
Etoposide—PTGS2—leg—multiple sclerosis	0.000512	0.0623	CbGeAlD
Etoposide—ABCC6—retina—multiple sclerosis	0.000434	0.0529	CbGeAlD
Etoposide—TOP2B—brainstem—multiple sclerosis	0.000408	0.0497	CbGeAlD
Etoposide—TOP2B—retina—multiple sclerosis	0.000394	0.048	CbGeAlD
Etoposide—GSTT1—nervous system—multiple sclerosis	0.00029	0.0354	CbGeAlD
Etoposide—TOP2B—medulla oblongata—multiple sclerosis	0.000285	0.0347	CbGeAlD
Etoposide—TOP2B—midbrain—multiple sclerosis	0.00026	0.0317	CbGeAlD
Etoposide—TOP2B—spinal cord—multiple sclerosis	0.000254	0.0309	CbGeAlD
Etoposide—GSTP1—retina—multiple sclerosis	0.000247	0.0301	CbGeAlD
Etoposide—TOP2B—nervous system—multiple sclerosis	0.000214	0.0261	CbGeAlD
Etoposide—TOP2B—central nervous system—multiple sclerosis	0.000206	0.0251	CbGeAlD
Etoposide—TOP2B—cerebellum—multiple sclerosis	0.000201	0.0245	CbGeAlD
Etoposide—GSTP1—medulla oblongata—multiple sclerosis	0.000178	0.0217	CbGeAlD
Etoposide—ABCC10—medulla oblongata—multiple sclerosis	0.000178	0.0217	CbGeAlD
Etoposide—TOP2B—brain—multiple sclerosis	0.000164	0.0199	CbGeAlD
Etoposide—GSTP1—midbrain—multiple sclerosis	0.000163	0.0199	CbGeAlD
Etoposide—ABCC10—midbrain—multiple sclerosis	0.000163	0.0198	CbGeAlD
Etoposide—GSTP1—spinal cord—multiple sclerosis	0.000159	0.0194	CbGeAlD
Etoposide—ABCC10—spinal cord—multiple sclerosis	0.000159	0.0194	CbGeAlD
Etoposide—PTGS2—Fluocinonide—Methylprednisolone—multiple sclerosis	0.000158	0.115	CbGdCrCtD
Etoposide—PTGS2—Fluocinonide—Betamethasone—multiple sclerosis	0.000156	0.113	CbGdCrCtD
Etoposide—PTGS2—Fluocinonide—Dexamethasone—multiple sclerosis	0.000156	0.113	CbGdCrCtD
Etoposide—PTGS2—Fluocinonide—Triamcinolone—multiple sclerosis	0.000152	0.111	CbGdCrCtD
Etoposide—TOP2A—Floxuridine—Cladribine—multiple sclerosis	0.000143	0.104	CbGdCrCtD
Etoposide—ABCC3—nervous system—multiple sclerosis	0.000135	0.0164	CbGeAlD
Etoposide—GSTP1—nervous system—multiple sclerosis	0.000134	0.0163	CbGeAlD
Etoposide—ABCC3—central nervous system—multiple sclerosis	0.00013	0.0158	CbGeAlD
Etoposide—GSTP1—central nervous system—multiple sclerosis	0.000129	0.0157	CbGeAlD
Etoposide—GSTP1—cerebellum—multiple sclerosis	0.000126	0.0154	CbGeAlD
Etoposide—ABCC10—cerebellum—multiple sclerosis	0.000126	0.0153	CbGeAlD
Etoposide—ABCG2—medulla oblongata—multiple sclerosis	0.000104	0.0127	CbGeAlD
Etoposide—ABCC3—brain—multiple sclerosis	0.000103	0.0125	CbGeAlD
Etoposide—GSTP1—brain—multiple sclerosis	0.000102	0.0125	CbGeAlD
Etoposide—ABCC10—brain—multiple sclerosis	0.000102	0.0125	CbGeAlD
Etoposide—TOP2A—Clofarabine—Cladribine—multiple sclerosis	9.99e-05	0.0727	CbGdCrCtD
Etoposide—PTGS2—Fluticasone Propionate—Methylprednisolone—multiple sclerosis	9.55e-05	0.0695	CbGdCrCtD
Etoposide—ABCG2—midbrain—multiple sclerosis	9.54e-05	0.0116	CbGeAlD
Etoposide—PTGS2—Fluticasone Propionate—Betamethasone—multiple sclerosis	9.4e-05	0.0684	CbGdCrCtD
Etoposide—PTGS2—Fluticasone Propionate—Dexamethasone—multiple sclerosis	9.4e-05	0.0684	CbGdCrCtD
Etoposide—ABCG2—spinal cord—multiple sclerosis	9.31e-05	0.0113	CbGeAlD
Etoposide—PTGS2—Fluticasone Propionate—Triamcinolone—multiple sclerosis	9.18e-05	0.0668	CbGdCrCtD
Etoposide—CYP2E1—medulla oblongata—multiple sclerosis	9.04e-05	0.011	CbGeAlD
Etoposide—ABCC1—cerebellum—multiple sclerosis	8.91e-05	0.0109	CbGeAlD
Etoposide—PTGS2—medulla oblongata—multiple sclerosis	8.32e-05	0.0101	CbGeAlD
Etoposide—CYP2E1—spinal cord—multiple sclerosis	8.06e-05	0.00981	CbGeAlD
Etoposide—PTGS1—spinal cord—multiple sclerosis	7.76e-05	0.00945	CbGeAlD
Etoposide—PTGS2—midbrain—multiple sclerosis	7.6e-05	0.00926	CbGeAlD
Etoposide—PTGS2—spinal cord—multiple sclerosis	7.42e-05	0.00904	CbGeAlD
Etoposide—ABCG2—cerebellum—multiple sclerosis	7.38e-05	0.00899	CbGeAlD
Etoposide—ABCC1—brain—multiple sclerosis	7.24e-05	0.00882	CbGeAlD
Etoposide—ABCB1—retina—multiple sclerosis	7.12e-05	0.00867	CbGeAlD
Etoposide—CYP2E1—nervous system—multiple sclerosis	6.79e-05	0.00827	CbGeAlD
Etoposide—PTGS1—nervous system—multiple sclerosis	6.54e-05	0.00797	CbGeAlD
Etoposide—CYP2E1—central nervous system—multiple sclerosis	6.54e-05	0.00796	CbGeAlD
Etoposide—CYP2E1—cerebellum—multiple sclerosis	6.39e-05	0.00778	CbGeAlD
Etoposide—PTGS1—central nervous system—multiple sclerosis	6.3e-05	0.00767	CbGeAlD
Etoposide—PTGS2—nervous system—multiple sclerosis	6.25e-05	0.00761	CbGeAlD
Etoposide—CYP2C8—brain—multiple sclerosis	6.16e-05	0.00751	CbGeAlD
Etoposide—TOP2A—Azacitidine—Cladribine—multiple sclerosis	6.09e-05	0.0443	CbGdCrCtD
Etoposide—PTGS2—central nervous system—multiple sclerosis	6.02e-05	0.00733	CbGeAlD
Etoposide—ABCG2—brain—multiple sclerosis	5.99e-05	0.0073	CbGeAlD
Etoposide—PTGS2—cerebellum—multiple sclerosis	5.88e-05	0.00716	CbGeAlD
Etoposide—Anaphylactic shock—Prednisolone—multiple sclerosis	5.5e-05	0.000824	CcSEcCtD
Etoposide—Neutropenia—Methotrexate—multiple sclerosis	5.49e-05	0.000822	CcSEcCtD
Etoposide—Dizziness—Azathioprine—multiple sclerosis	5.48e-05	0.000821	CcSEcCtD
Etoposide—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	5.48e-05	0.000821	CcSEcCtD
Etoposide—CYP3A4—nervous system—multiple sclerosis	5.46e-05	0.00665	CbGeAlD
Etoposide—Loss of consciousness—Triamcinolone—multiple sclerosis	5.44e-05	0.000816	CcSEcCtD
Etoposide—Loss of consciousness—Methylprednisolone—multiple sclerosis	5.43e-05	0.000814	CcSEcCtD
Etoposide—Cough—Triamcinolone—multiple sclerosis	5.41e-05	0.00081	CcSEcCtD
Etoposide—Convulsion—Triamcinolone—multiple sclerosis	5.37e-05	0.000804	CcSEcCtD
Etoposide—Tachycardia—Prednisolone—multiple sclerosis	5.37e-05	0.000804	CcSEcCtD
Etoposide—Convulsion—Methylprednisolone—multiple sclerosis	5.36e-05	0.000802	CcSEcCtD
Etoposide—Hypertension—Triamcinolone—multiple sclerosis	5.35e-05	0.000801	CcSEcCtD
Etoposide—Hypertension—Methylprednisolone—multiple sclerosis	5.34e-05	0.000799	CcSEcCtD
Etoposide—Urticaria—Mitoxantrone—multiple sclerosis	5.32e-05	0.000798	CcSEcCtD
Etoposide—Hyperhidrosis—Prednisolone—multiple sclerosis	5.31e-05	0.000796	CcSEcCtD
Etoposide—Abdominal pain—Mitoxantrone—multiple sclerosis	5.3e-05	0.000794	CcSEcCtD
Etoposide—Body temperature increased—Mitoxantrone—multiple sclerosis	5.3e-05	0.000794	CcSEcCtD
Etoposide—Vomiting—Azathioprine—multiple sclerosis	5.27e-05	0.00079	CcSEcCtD
Etoposide—Pneumonia—Methotrexate—multiple sclerosis	5.27e-05	0.000789	CcSEcCtD
Etoposide—CYP3A4—central nervous system—multiple sclerosis	5.26e-05	0.00641	CbGeAlD
Etoposide—Eye disorder—Prednisone—multiple sclerosis	5.25e-05	0.000787	CcSEcCtD
Etoposide—Infestation—Methotrexate—multiple sclerosis	5.23e-05	0.000784	CcSEcCtD
Etoposide—Infestation NOS—Methotrexate—multiple sclerosis	5.23e-05	0.000784	CcSEcCtD
Etoposide—Rash—Azathioprine—multiple sclerosis	5.23e-05	0.000783	CcSEcCtD
Etoposide—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	5.23e-05	0.000783	CcSEcCtD
Etoposide—Dermatitis—Azathioprine—multiple sclerosis	5.22e-05	0.000782	CcSEcCtD
Etoposide—Flushing—Prednisone—multiple sclerosis	5.22e-05	0.000782	CcSEcCtD
Etoposide—Ill-defined disorder—Dexamethasone—multiple sclerosis	5.22e-05	0.000781	CcSEcCtD
Etoposide—Ill-defined disorder—Betamethasone—multiple sclerosis	5.22e-05	0.000781	CcSEcCtD
Etoposide—Discomfort—Triamcinolone—multiple sclerosis	5.21e-05	0.000781	CcSEcCtD
Etoposide—Discomfort—Methylprednisolone—multiple sclerosis	5.2e-05	0.000779	CcSEcCtD
Etoposide—Headache—Azathioprine—multiple sclerosis	5.19e-05	0.000778	CcSEcCtD
Etoposide—Stevens-Johnson syndrome—Methotrexate—multiple sclerosis	5.19e-05	0.000778	CcSEcCtD
Etoposide—CYP2E1—brain—multiple sclerosis	5.19e-05	0.00632	CbGeAlD
Etoposide—ABCB1—medulla oblongata—multiple sclerosis	5.15e-05	0.00627	CbGeAlD
Etoposide—Renal failure—Methotrexate—multiple sclerosis	5.15e-05	0.000771	CcSEcCtD
Etoposide—Stomatitis—Methotrexate—multiple sclerosis	5.1e-05	0.000764	CcSEcCtD
Etoposide—Angiopathy—Prednisone—multiple sclerosis	5.1e-05	0.000764	CcSEcCtD
Etoposide—Confusional state—Methylprednisolone—multiple sclerosis	5.09e-05	0.000762	CcSEcCtD
Etoposide—Immune system disorder—Prednisone—multiple sclerosis	5.08e-05	0.000761	CcSEcCtD
Etoposide—Malaise—Betamethasone—multiple sclerosis	5.07e-05	0.000759	CcSEcCtD
Etoposide—Malaise—Dexamethasone—multiple sclerosis	5.07e-05	0.000759	CcSEcCtD
Etoposide—Anaphylactic shock—Triamcinolone—multiple sclerosis	5.06e-05	0.000757	CcSEcCtD
Etoposide—Vertigo—Dexamethasone—multiple sclerosis	5.05e-05	0.000757	CcSEcCtD
Etoposide—Vertigo—Betamethasone—multiple sclerosis	5.05e-05	0.000757	CcSEcCtD
Etoposide—Anaphylactic shock—Methylprednisolone—multiple sclerosis	5.04e-05	0.000756	CcSEcCtD
Etoposide—Infection—Triamcinolone—multiple sclerosis	5.02e-05	0.000752	CcSEcCtD
Etoposide—Infection—Methylprednisolone—multiple sclerosis	5.01e-05	0.000751	CcSEcCtD
Etoposide—PTGS1—brain—multiple sclerosis	5e-05	0.00609	CbGeAlD
Etoposide—Alopecia—Prednisone—multiple sclerosis	4.97e-05	0.000744	CcSEcCtD
Etoposide—Hepatobiliary disease—Methotrexate—multiple sclerosis	4.95e-05	0.000742	CcSEcCtD
Etoposide—Loss of consciousness—Dexamethasone—multiple sclerosis	4.94e-05	0.00074	CcSEcCtD
Etoposide—Loss of consciousness—Betamethasone—multiple sclerosis	4.94e-05	0.00074	CcSEcCtD
Etoposide—Hypersensitivity—Mitoxantrone—multiple sclerosis	4.94e-05	0.00074	CcSEcCtD
Etoposide—Paraesthesia—Prednisolone—multiple sclerosis	4.94e-05	0.00074	CcSEcCtD
Etoposide—Tachycardia—Triamcinolone—multiple sclerosis	4.93e-05	0.000739	CcSEcCtD
Etoposide—Nausea—Azathioprine—multiple sclerosis	4.92e-05	0.000738	CcSEcCtD
Etoposide—Tachycardia—Methylprednisolone—multiple sclerosis	4.92e-05	0.000738	CcSEcCtD
Etoposide—Skin disorder—Methylprednisolone—multiple sclerosis	4.9e-05	0.000734	CcSEcCtD
Etoposide—Hyperhidrosis—Triamcinolone—multiple sclerosis	4.89e-05	0.000732	CcSEcCtD
Etoposide—Agranulocytosis—Methotrexate—multiple sclerosis	4.89e-05	0.000732	CcSEcCtD
Etoposide—Hyperhidrosis—Methylprednisolone—multiple sclerosis	4.88e-05	0.000731	CcSEcCtD
Etoposide—Convulsion—Dexamethasone—multiple sclerosis	4.87e-05	0.00073	CcSEcCtD
Etoposide—Convulsion—Betamethasone—multiple sclerosis	4.87e-05	0.00073	CcSEcCtD
Etoposide—Hypertension—Betamethasone—multiple sclerosis	4.85e-05	0.000727	CcSEcCtD
Etoposide—Hypertension—Dexamethasone—multiple sclerosis	4.85e-05	0.000727	CcSEcCtD
Etoposide—Asthenia—Mitoxantrone—multiple sclerosis	4.81e-05	0.00072	CcSEcCtD
Etoposide—PTGS2—brain—multiple sclerosis	4.78e-05	0.00582	CbGeAlD
Etoposide—Discomfort—Dexamethasone—multiple sclerosis	4.73e-05	0.000708	CcSEcCtD
Etoposide—Discomfort—Betamethasone—multiple sclerosis	4.73e-05	0.000708	CcSEcCtD
Etoposide—Hypotension—Methylprednisolone—multiple sclerosis	4.71e-05	0.000706	CcSEcCtD
Etoposide—ABCB1—midbrain—multiple sclerosis	4.7e-05	0.00573	CbGeAlD
Etoposide—Pain—Prednisolone—multiple sclerosis	4.7e-05	0.000704	CcSEcCtD
Etoposide—Urinary tract disorder—Methotrexate—multiple sclerosis	4.64e-05	0.000695	CcSEcCtD
Etoposide—Urethral disorder—Methotrexate—multiple sclerosis	4.61e-05	0.00069	CcSEcCtD
Etoposide—ABCB1—spinal cord—multiple sclerosis	4.59e-05	0.00559	CbGeAlD
Etoposide—Anaphylactic shock—Dexamethasone—multiple sclerosis	4.59e-05	0.000687	CcSEcCtD
Etoposide—Anaphylactic shock—Betamethasone—multiple sclerosis	4.59e-05	0.000687	CcSEcCtD
Etoposide—Diarrhoea—Mitoxantrone—multiple sclerosis	4.58e-05	0.000687	CcSEcCtD
Etoposide—Infection—Dexamethasone—multiple sclerosis	4.56e-05	0.000683	CcSEcCtD
Etoposide—Infection—Betamethasone—multiple sclerosis	4.56e-05	0.000683	CcSEcCtD
Etoposide—Ill-defined disorder—Prednisone—multiple sclerosis	4.54e-05	0.00068	CcSEcCtD
Etoposide—Paraesthesia—Triamcinolone—multiple sclerosis	4.54e-05	0.00068	CcSEcCtD
Etoposide—Feeling abnormal—Prednisolone—multiple sclerosis	4.53e-05	0.000679	CcSEcCtD
Etoposide—Paraesthesia—Methylprednisolone—multiple sclerosis	4.53e-05	0.000679	CcSEcCtD
Etoposide—Anaemia—Prednisone—multiple sclerosis	4.52e-05	0.000678	CcSEcCtD
Etoposide—Dyspnoea—Triamcinolone—multiple sclerosis	4.51e-05	0.000675	CcSEcCtD
Etoposide—Thrombocytopenia—Betamethasone—multiple sclerosis	4.49e-05	0.000673	CcSEcCtD
Etoposide—Thrombocytopenia—Dexamethasone—multiple sclerosis	4.49e-05	0.000673	CcSEcCtD
Etoposide—Tachycardia—Betamethasone—multiple sclerosis	4.48e-05	0.000671	CcSEcCtD
Etoposide—Tachycardia—Dexamethasone—multiple sclerosis	4.48e-05	0.000671	CcSEcCtD
Etoposide—Erythema multiforme—Methotrexate—multiple sclerosis	4.44e-05	0.000666	CcSEcCtD
Etoposide—Hyperhidrosis—Dexamethasone—multiple sclerosis	4.43e-05	0.000664	CcSEcCtD
Etoposide—Hyperhidrosis—Betamethasone—multiple sclerosis	4.43e-05	0.000664	CcSEcCtD
Etoposide—Malaise—Prednisone—multiple sclerosis	4.41e-05	0.000661	CcSEcCtD
Etoposide—Vertigo—Prednisone—multiple sclerosis	4.4e-05	0.000659	CcSEcCtD
Etoposide—Eye disorder—Methotrexate—multiple sclerosis	4.39e-05	0.000658	CcSEcCtD
Etoposide—Anorexia—Betamethasone—multiple sclerosis	4.37e-05	0.000655	CcSEcCtD
Etoposide—Anorexia—Dexamethasone—multiple sclerosis	4.37e-05	0.000655	CcSEcCtD
Etoposide—Urticaria—Prednisolone—multiple sclerosis	4.37e-05	0.000654	CcSEcCtD
Etoposide—Cardiac disorder—Methotrexate—multiple sclerosis	4.36e-05	0.000653	CcSEcCtD
Etoposide—Fatigue—Triamcinolone—multiple sclerosis	4.36e-05	0.000653	CcSEcCtD
Etoposide—Fatigue—Methylprednisolone—multiple sclerosis	4.35e-05	0.000652	CcSEcCtD
Etoposide—Pain—Triamcinolone—multiple sclerosis	4.32e-05	0.000648	CcSEcCtD
Etoposide—Loss of consciousness—Prednisone—multiple sclerosis	4.3e-05	0.000645	CcSEcCtD
Etoposide—Hypotension—Dexamethasone—multiple sclerosis	4.29e-05	0.000642	CcSEcCtD
Etoposide—Hypotension—Betamethasone—multiple sclerosis	4.29e-05	0.000642	CcSEcCtD
Etoposide—Angiopathy—Methotrexate—multiple sclerosis	4.26e-05	0.000639	CcSEcCtD
Etoposide—Vomiting—Mitoxantrone—multiple sclerosis	4.26e-05	0.000638	CcSEcCtD
Etoposide—Immune system disorder—Methotrexate—multiple sclerosis	4.24e-05	0.000636	CcSEcCtD
Etoposide—Convulsion—Prednisone—multiple sclerosis	4.24e-05	0.000635	CcSEcCtD
Etoposide—Mediastinal disorder—Methotrexate—multiple sclerosis	4.24e-05	0.000635	CcSEcCtD
Etoposide—Hypertension—Prednisone—multiple sclerosis	4.23e-05	0.000633	CcSEcCtD
Etoposide—Rash—Mitoxantrone—multiple sclerosis	4.23e-05	0.000633	CcSEcCtD
Etoposide—Dermatitis—Mitoxantrone—multiple sclerosis	4.22e-05	0.000632	CcSEcCtD
Etoposide—Chills—Methotrexate—multiple sclerosis	4.22e-05	0.000632	CcSEcCtD
Etoposide—Headache—Mitoxantrone—multiple sclerosis	4.2e-05	0.000629	CcSEcCtD
Etoposide—Feeling abnormal—Triamcinolone—multiple sclerosis	4.17e-05	0.000624	CcSEcCtD
Etoposide—Feeling abnormal—Methylprednisolone—multiple sclerosis	4.16e-05	0.000623	CcSEcCtD
Etoposide—Alopecia—Methotrexate—multiple sclerosis	4.15e-05	0.000622	CcSEcCtD
Etoposide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	4.14e-05	0.00062	CcSEcCtD
Etoposide—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	4.12e-05	0.000618	CcSEcCtD
Etoposide—Paraesthesia—Betamethasone—multiple sclerosis	4.12e-05	0.000617	CcSEcCtD
Etoposide—Paraesthesia—Dexamethasone—multiple sclerosis	4.12e-05	0.000617	CcSEcCtD
Etoposide—Discomfort—Prednisone—multiple sclerosis	4.12e-05	0.000617	CcSEcCtD
Etoposide—Hypersensitivity—Prednisolone—multiple sclerosis	4.05e-05	0.000607	CcSEcCtD
Etoposide—Urticaria—Triamcinolone—multiple sclerosis	4.02e-05	0.000602	CcSEcCtD
Etoposide—Urticaria—Methylprednisolone—multiple sclerosis	4.01e-05	0.0006	CcSEcCtD
Etoposide—Dysgeusia—Methotrexate—multiple sclerosis	4.01e-05	0.0006	CcSEcCtD
Etoposide—Body temperature increased—Triamcinolone—multiple sclerosis	4e-05	0.000599	CcSEcCtD
Etoposide—Anaphylactic shock—Prednisone—multiple sclerosis	3.99e-05	0.000598	CcSEcCtD
Etoposide—Abdominal pain—Methylprednisolone—multiple sclerosis	3.99e-05	0.000597	CcSEcCtD
Etoposide—Decreased appetite—Dexamethasone—multiple sclerosis	3.99e-05	0.000597	CcSEcCtD
Etoposide—Decreased appetite—Betamethasone—multiple sclerosis	3.99e-05	0.000597	CcSEcCtD
Etoposide—Nausea—Mitoxantrone—multiple sclerosis	3.98e-05	0.000596	CcSEcCtD
Etoposide—Infection—Prednisone—multiple sclerosis	3.97e-05	0.000595	CcSEcCtD
Etoposide—Gastrointestinal disorder—Betamethasone—multiple sclerosis	3.96e-05	0.000593	CcSEcCtD
Etoposide—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	3.96e-05	0.000593	CcSEcCtD
Etoposide—Back pain—Methotrexate—multiple sclerosis	3.96e-05	0.000593	CcSEcCtD
Etoposide—Fatigue—Betamethasone—multiple sclerosis	3.95e-05	0.000593	CcSEcCtD
Etoposide—Fatigue—Dexamethasone—multiple sclerosis	3.95e-05	0.000593	CcSEcCtD
Etoposide—Pain—Betamethasone—multiple sclerosis	3.92e-05	0.000588	CcSEcCtD
Etoposide—Pain—Dexamethasone—multiple sclerosis	3.92e-05	0.000588	CcSEcCtD
Etoposide—Tachycardia—Prednisone—multiple sclerosis	3.9e-05	0.000584	CcSEcCtD
Etoposide—Skin disorder—Prednisone—multiple sclerosis	3.88e-05	0.000581	CcSEcCtD
Etoposide—ABCB1—nervous system—multiple sclerosis	3.87e-05	0.00471	CbGeAlD
Etoposide—Hyperhidrosis—Prednisone—multiple sclerosis	3.86e-05	0.000579	CcSEcCtD
Etoposide—Anorexia—Prednisone—multiple sclerosis	3.81e-05	0.00057	CcSEcCtD
Etoposide—Ill-defined disorder—Methotrexate—multiple sclerosis	3.8e-05	0.000569	CcSEcCtD
Etoposide—Anaemia—Methotrexate—multiple sclerosis	3.78e-05	0.000566	CcSEcCtD
Etoposide—Feeling abnormal—Dexamethasone—multiple sclerosis	3.78e-05	0.000566	CcSEcCtD
Etoposide—Feeling abnormal—Betamethasone—multiple sclerosis	3.78e-05	0.000566	CcSEcCtD
Etoposide—Gastrointestinal pain—Dexamethasone—multiple sclerosis	3.75e-05	0.000562	CcSEcCtD
Etoposide—Gastrointestinal pain—Betamethasone—multiple sclerosis	3.75e-05	0.000562	CcSEcCtD
Etoposide—TOP2A—Methyltestosterone—Prednisone—multiple sclerosis	3.73e-05	0.0272	CbGdCrCtD
Etoposide—Hypersensitivity—Triamcinolone—multiple sclerosis	3.72e-05	0.000558	CcSEcCtD
Etoposide—ABCB1—central nervous system—multiple sclerosis	3.72e-05	0.00453	CbGeAlD
Etoposide—Hypersensitivity—Methylprednisolone—multiple sclerosis	3.72e-05	0.000557	CcSEcCtD
Etoposide—Malaise—Methotrexate—multiple sclerosis	3.69e-05	0.000553	CcSEcCtD
Etoposide—Vertigo—Methotrexate—multiple sclerosis	3.68e-05	0.000551	CcSEcCtD
Etoposide—Leukopenia—Methotrexate—multiple sclerosis	3.66e-05	0.000549	CcSEcCtD
Etoposide—Urticaria—Dexamethasone—multiple sclerosis	3.64e-05	0.000546	CcSEcCtD
Etoposide—Urticaria—Betamethasone—multiple sclerosis	3.64e-05	0.000546	CcSEcCtD
Etoposide—TOP2A—Methyltestosterone—Prednisolone—multiple sclerosis	3.64e-05	0.0265	CbGdCrCtD
Etoposide—ABCB1—cerebellum—multiple sclerosis	3.64e-05	0.00443	CbGeAlD
Etoposide—Dizziness—Prednisolone—multiple sclerosis	3.64e-05	0.000545	CcSEcCtD
Etoposide—Asthenia—Triamcinolone—multiple sclerosis	3.63e-05	0.000543	CcSEcCtD
Etoposide—Abdominal pain—Dexamethasone—multiple sclerosis	3.63e-05	0.000543	CcSEcCtD
Etoposide—Abdominal pain—Betamethasone—multiple sclerosis	3.63e-05	0.000543	CcSEcCtD
Etoposide—Body temperature increased—Betamethasone—multiple sclerosis	3.63e-05	0.000543	CcSEcCtD
Etoposide—Body temperature increased—Dexamethasone—multiple sclerosis	3.63e-05	0.000543	CcSEcCtD
Etoposide—Asthenia—Methylprednisolone—multiple sclerosis	3.62e-05	0.000542	CcSEcCtD
Etoposide—Paraesthesia—Prednisone—multiple sclerosis	3.59e-05	0.000537	CcSEcCtD
Etoposide—Pruritus—Triamcinolone—multiple sclerosis	3.58e-05	0.000536	CcSEcCtD
Etoposide—Cough—Methotrexate—multiple sclerosis	3.57e-05	0.000535	CcSEcCtD
Etoposide—Pruritus—Methylprednisolone—multiple sclerosis	3.57e-05	0.000535	CcSEcCtD
Etoposide—Convulsion—Methotrexate—multiple sclerosis	3.54e-05	0.000531	CcSEcCtD
Etoposide—Chest pain—Methotrexate—multiple sclerosis	3.48e-05	0.000522	CcSEcCtD
Etoposide—Decreased appetite—Prednisone—multiple sclerosis	3.47e-05	0.00052	CcSEcCtD
Etoposide—Rash—Prednisolone—multiple sclerosis	3.47e-05	0.000519	CcSEcCtD
Etoposide—Dermatitis—Prednisolone—multiple sclerosis	3.46e-05	0.000519	CcSEcCtD
Etoposide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	3.46e-05	0.000518	CcSEcCtD
Etoposide—Diarrhoea—Methylprednisolone—multiple sclerosis	3.45e-05	0.000517	CcSEcCtD
Etoposide—Fatigue—Prednisone—multiple sclerosis	3.44e-05	0.000516	CcSEcCtD
Etoposide—Headache—Prednisolone—multiple sclerosis	3.44e-05	0.000516	CcSEcCtD
Etoposide—Discomfort—Methotrexate—multiple sclerosis	3.44e-05	0.000516	CcSEcCtD
Etoposide—Constipation—Prednisone—multiple sclerosis	3.42e-05	0.000512	CcSEcCtD
Etoposide—Confusional state—Methotrexate—multiple sclerosis	3.37e-05	0.000504	CcSEcCtD
Etoposide—Dizziness—Triamcinolone—multiple sclerosis	3.34e-05	0.000501	CcSEcCtD
Etoposide—Anaphylactic shock—Methotrexate—multiple sclerosis	3.34e-05	0.0005	CcSEcCtD
Etoposide—Dizziness—Methylprednisolone—multiple sclerosis	3.34e-05	0.0005	CcSEcCtD
Etoposide—Infection—Methotrexate—multiple sclerosis	3.32e-05	0.000497	CcSEcCtD
Etoposide—Feeling abnormal—Prednisone—multiple sclerosis	3.29e-05	0.000493	CcSEcCtD
Etoposide—Asthenia—Betamethasone—multiple sclerosis	3.29e-05	0.000493	CcSEcCtD
Etoposide—Asthenia—Dexamethasone—multiple sclerosis	3.29e-05	0.000493	CcSEcCtD
Etoposide—Thrombocytopenia—Methotrexate—multiple sclerosis	3.27e-05	0.00049	CcSEcCtD
Etoposide—Gastrointestinal pain—Prednisone—multiple sclerosis	3.27e-05	0.000489	CcSEcCtD
Etoposide—Nausea—Prednisolone—multiple sclerosis	3.27e-05	0.000489	CcSEcCtD
Etoposide—Pruritus—Betamethasone—multiple sclerosis	3.25e-05	0.000486	CcSEcCtD
Etoposide—Pruritus—Dexamethasone—multiple sclerosis	3.25e-05	0.000486	CcSEcCtD
Etoposide—Skin disorder—Methotrexate—multiple sclerosis	3.24e-05	0.000486	CcSEcCtD
Etoposide—Hyperhidrosis—Methotrexate—multiple sclerosis	3.23e-05	0.000484	CcSEcCtD
Etoposide—Vomiting—Triamcinolone—multiple sclerosis	3.21e-05	0.000482	CcSEcCtD
Etoposide—Vomiting—Methylprednisolone—multiple sclerosis	3.21e-05	0.000481	CcSEcCtD
Etoposide—Rash—Triamcinolone—multiple sclerosis	3.19e-05	0.000478	CcSEcCtD
Etoposide—Dermatitis—Triamcinolone—multiple sclerosis	3.18e-05	0.000477	CcSEcCtD
Etoposide—Anorexia—Methotrexate—multiple sclerosis	3.18e-05	0.000477	CcSEcCtD
Etoposide—Rash—Methylprednisolone—multiple sclerosis	3.18e-05	0.000476	CcSEcCtD
Etoposide—Dermatitis—Methylprednisolone—multiple sclerosis	3.18e-05	0.000476	CcSEcCtD
Etoposide—Urticaria—Prednisone—multiple sclerosis	3.17e-05	0.000475	CcSEcCtD
Etoposide—Headache—Triamcinolone—multiple sclerosis	3.17e-05	0.000474	CcSEcCtD
Etoposide—Headache—Methylprednisolone—multiple sclerosis	3.16e-05	0.000473	CcSEcCtD
Etoposide—Abdominal pain—Prednisone—multiple sclerosis	3.16e-05	0.000473	CcSEcCtD
Etoposide—Body temperature increased—Prednisone—multiple sclerosis	3.16e-05	0.000473	CcSEcCtD
Etoposide—Diarrhoea—Dexamethasone—multiple sclerosis	3.14e-05	0.00047	CcSEcCtD
Etoposide—Diarrhoea—Betamethasone—multiple sclerosis	3.14e-05	0.00047	CcSEcCtD
Etoposide—Hypotension—Methotrexate—multiple sclerosis	3.12e-05	0.000467	CcSEcCtD
Etoposide—Dizziness—Dexamethasone—multiple sclerosis	3.03e-05	0.000454	CcSEcCtD
Etoposide—Dizziness—Betamethasone—multiple sclerosis	3.03e-05	0.000454	CcSEcCtD
Etoposide—Nausea—Triamcinolone—multiple sclerosis	3e-05	0.00045	CcSEcCtD
Etoposide—Paraesthesia—Methotrexate—multiple sclerosis	3e-05	0.000449	CcSEcCtD
Etoposide—Nausea—Methylprednisolone—multiple sclerosis	3e-05	0.000449	CcSEcCtD
Etoposide—Dyspnoea—Methotrexate—multiple sclerosis	2.98e-05	0.000446	CcSEcCtD
Etoposide—Somnolence—Methotrexate—multiple sclerosis	2.97e-05	0.000445	CcSEcCtD
Etoposide—ABCB1—brain—multiple sclerosis	2.96e-05	0.0036	CbGeAlD
Etoposide—Hypersensitivity—Prednisone—multiple sclerosis	2.94e-05	0.000441	CcSEcCtD
Etoposide—Vomiting—Dexamethasone—multiple sclerosis	2.92e-05	0.000437	CcSEcCtD
Etoposide—Vomiting—Betamethasone—multiple sclerosis	2.92e-05	0.000437	CcSEcCtD
Etoposide—Decreased appetite—Methotrexate—multiple sclerosis	2.9e-05	0.000435	CcSEcCtD
Etoposide—Rash—Betamethasone—multiple sclerosis	2.89e-05	0.000433	CcSEcCtD
Etoposide—Rash—Dexamethasone—multiple sclerosis	2.89e-05	0.000433	CcSEcCtD
Etoposide—Dermatitis—Betamethasone—multiple sclerosis	2.89e-05	0.000433	CcSEcCtD
Etoposide—Dermatitis—Dexamethasone—multiple sclerosis	2.89e-05	0.000433	CcSEcCtD
Etoposide—Gastrointestinal disorder—Methotrexate—multiple sclerosis	2.88e-05	0.000432	CcSEcCtD
Etoposide—Fatigue—Methotrexate—multiple sclerosis	2.88e-05	0.000431	CcSEcCtD
Etoposide—Headache—Betamethasone—multiple sclerosis	2.87e-05	0.000431	CcSEcCtD
Etoposide—Headache—Dexamethasone—multiple sclerosis	2.87e-05	0.000431	CcSEcCtD
Etoposide—Asthenia—Prednisone—multiple sclerosis	2.87e-05	0.000429	CcSEcCtD
Etoposide—Pain—Methotrexate—multiple sclerosis	2.85e-05	0.000428	CcSEcCtD
Etoposide—Pruritus—Prednisone—multiple sclerosis	2.83e-05	0.000423	CcSEcCtD
Etoposide—Feeling abnormal—Methotrexate—multiple sclerosis	2.75e-05	0.000412	CcSEcCtD
Etoposide—Diarrhoea—Prednisone—multiple sclerosis	2.73e-05	0.000409	CcSEcCtD
Etoposide—Gastrointestinal pain—Methotrexate—multiple sclerosis	2.73e-05	0.000409	CcSEcCtD
Etoposide—Nausea—Dexamethasone—multiple sclerosis	2.72e-05	0.000408	CcSEcCtD
Etoposide—Nausea—Betamethasone—multiple sclerosis	2.72e-05	0.000408	CcSEcCtD
Etoposide—Urticaria—Methotrexate—multiple sclerosis	2.65e-05	0.000397	CcSEcCtD
Etoposide—Dizziness—Prednisone—multiple sclerosis	2.64e-05	0.000396	CcSEcCtD
Etoposide—Abdominal pain—Methotrexate—multiple sclerosis	2.64e-05	0.000395	CcSEcCtD
Etoposide—Body temperature increased—Methotrexate—multiple sclerosis	2.64e-05	0.000395	CcSEcCtD
Etoposide—Vomiting—Prednisone—multiple sclerosis	2.54e-05	0.000381	CcSEcCtD
Etoposide—Rash—Prednisone—multiple sclerosis	2.52e-05	0.000377	CcSEcCtD
Etoposide—Dermatitis—Prednisone—multiple sclerosis	2.52e-05	0.000377	CcSEcCtD
Etoposide—Headache—Prednisone—multiple sclerosis	2.5e-05	0.000375	CcSEcCtD
Etoposide—Hypersensitivity—Methotrexate—multiple sclerosis	2.46e-05	0.000369	CcSEcCtD
Etoposide—Asthenia—Methotrexate—multiple sclerosis	2.4e-05	0.000359	CcSEcCtD
Etoposide—Nausea—Prednisone—multiple sclerosis	2.37e-05	0.000355	CcSEcCtD
Etoposide—Pruritus—Methotrexate—multiple sclerosis	2.36e-05	0.000354	CcSEcCtD
Etoposide—Diarrhoea—Methotrexate—multiple sclerosis	2.28e-05	0.000342	CcSEcCtD
Etoposide—Dizziness—Methotrexate—multiple sclerosis	2.21e-05	0.000331	CcSEcCtD
Etoposide—Vomiting—Methotrexate—multiple sclerosis	2.12e-05	0.000318	CcSEcCtD
Etoposide—Rash—Methotrexate—multiple sclerosis	2.11e-05	0.000315	CcSEcCtD
Etoposide—Dermatitis—Methotrexate—multiple sclerosis	2.1e-05	0.000315	CcSEcCtD
Etoposide—Headache—Methotrexate—multiple sclerosis	2.09e-05	0.000313	CcSEcCtD
Etoposide—Nausea—Methotrexate—multiple sclerosis	1.98e-05	0.000297	CcSEcCtD
Etoposide—ABCC2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	1.59e-05	0.000844	CbGpPWpGaD
Etoposide—ABCB1—Allograft Rejection—CD80—multiple sclerosis	1.59e-05	0.000842	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	1.59e-05	0.000841	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	1.59e-05	0.000841	CbGpPWpGaD
Etoposide—ABCC1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	1.57e-05	0.000834	CbGpPWpGaD
Etoposide—ABCG2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	1.57e-05	0.00083	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	1.56e-05	0.000825	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—SRM—multiple sclerosis	1.55e-05	0.000823	CbGpPWpGaD
Etoposide—GSTP1—Cellular responses to stress—STAT3—multiple sclerosis	1.55e-05	0.000823	CbGpPWpGaD
Etoposide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—multiple sclerosis	1.54e-05	0.000819	CbGpPWpGaD
Etoposide—PTGS2—Spinal Cord Injury—CCL2—multiple sclerosis	1.51e-05	0.000801	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—GPC5—multiple sclerosis	1.51e-05	0.000801	CbGpPWpGaD
Etoposide—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	1.5e-05	0.000796	CbGpPWpGaD
Etoposide—PTGS2—Selenium Micronutrient Network—IL1B—multiple sclerosis	1.45e-05	0.000768	CbGpPWpGaD
Etoposide—PTGS1—Biological oxidations—POMC—multiple sclerosis	1.44e-05	0.000763	CbGpPWpGaD
Etoposide—ABCC3—NRF2 pathway—TGFB1—multiple sclerosis	1.43e-05	0.000757	CbGpPWpGaD
Etoposide—ABCB1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	1.41e-05	0.000749	CbGpPWpGaD
Etoposide—ABCC1—Disease—GPC5—multiple sclerosis	1.41e-05	0.000749	CbGpPWpGaD
Etoposide—GSTP1—Cellular responses to stress—MAPK1—multiple sclerosis	1.41e-05	0.000748	CbGpPWpGaD
Etoposide—ABCG2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	1.39e-05	0.000734	CbGpPWpGaD
Etoposide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	1.38e-05	0.00073	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	1.37e-05	0.000729	CbGpPWpGaD
Etoposide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	1.37e-05	0.000727	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—CYP27B1—multiple sclerosis	1.34e-05	0.000711	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—CYP24A1—multiple sclerosis	1.34e-05	0.000711	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	1.33e-05	0.000706	CbGpPWpGaD
Etoposide—PTGS1—Selenium Micronutrient Network—TNF—multiple sclerosis	1.32e-05	0.000702	CbGpPWpGaD
Etoposide—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	1.31e-05	0.000693	CbGpPWpGaD
Etoposide—TOP2A—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	1.3e-05	0.000691	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—CYP24A1—multiple sclerosis	1.29e-05	0.000686	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—CYP27B1—multiple sclerosis	1.29e-05	0.000686	CbGpPWpGaD
Etoposide—PTGS2—Spinal Cord Injury—IFNG—multiple sclerosis	1.28e-05	0.000681	CbGpPWpGaD
Etoposide—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	1.28e-05	0.000678	CbGpPWpGaD
Etoposide—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	1.28e-05	0.000677	CbGpPWpGaD
Etoposide—GSTT1—Metabolism—APOE—multiple sclerosis	1.28e-05	0.000677	CbGpPWpGaD
Etoposide—ABCC1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.26e-05	0.00067	CbGpPWpGaD
Etoposide—ABCB1—Allograft Rejection—IFNG—multiple sclerosis	1.26e-05	0.000665	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—RRM1—multiple sclerosis	1.25e-05	0.000663	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—SRM—multiple sclerosis	1.23e-05	0.000653	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—GPC5—multiple sclerosis	1.23e-05	0.000651	CbGpPWpGaD
Etoposide—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	1.22e-05	0.000645	CbGpPWpGaD
Etoposide—CYP1A2—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	1.22e-05	0.000645	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—GPC5—multiple sclerosis	1.18e-05	0.000627	CbGpPWpGaD
Etoposide—PTGS2—C-MYB transcription factor network—MYC—multiple sclerosis	1.17e-05	0.000621	CbGpPWpGaD
Etoposide—GSTP1—Metabolism—BCHE—multiple sclerosis	1.16e-05	0.000617	CbGpPWpGaD
Etoposide—UGT1A1—NRF2 pathway—TGFB1—multiple sclerosis	1.16e-05	0.000615	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—SRM—multiple sclerosis	1.16e-05	0.000615	CbGpPWpGaD
Etoposide—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	1.16e-05	0.000614	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—SRM—multiple sclerosis	1.16e-05	0.000614	CbGpPWpGaD
Etoposide—PTGS2—Spinal Cord Injury—IL1B—multiple sclerosis	1.15e-05	0.000607	CbGpPWpGaD
Etoposide—PTGS2—Spinal Cord Injury—IL2—multiple sclerosis	1.14e-05	0.000605	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—CYP27B1—multiple sclerosis	1.14e-05	0.000603	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—CYP24A1—multiple sclerosis	1.14e-05	0.000603	CbGpPWpGaD
Etoposide—ABCC2—NRF2 pathway—TGFB1—multiple sclerosis	1.13e-05	0.0006	CbGpPWpGaD
Etoposide—ABCB1—Allograft Rejection—IL1B—multiple sclerosis	1.12e-05	0.000593	CbGpPWpGaD
Etoposide—ABCB1—Allograft Rejection—IL2—multiple sclerosis	1.12e-05	0.000591	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	1.1e-05	0.000585	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	1.1e-05	0.000585	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	1.1e-05	0.000585	CbGpPWpGaD
Etoposide—GSTT1—Metabolism—POMC—multiple sclerosis	1.1e-05	0.000582	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—CYP27B1—multiple sclerosis	1.09e-05	0.00058	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—CYP24A1—multiple sclerosis	1.09e-05	0.00058	CbGpPWpGaD
Etoposide—GSTP1—Cellular responses to stress—IL6—multiple sclerosis	1.08e-05	0.000575	CbGpPWpGaD
Etoposide—PTGS2—Spinal Cord Injury—MMP9—multiple sclerosis	1.08e-05	0.000573	CbGpPWpGaD
Etoposide—CYP2E1—Biological oxidations—POMC—multiple sclerosis	1.08e-05	0.00057	CbGpPWpGaD
Etoposide—CYP1A2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	1.07e-05	0.000569	CbGpPWpGaD
Etoposide—CYP3A5—Biological oxidations—POMC—multiple sclerosis	1.07e-05	0.000569	CbGpPWpGaD
Etoposide—ABCB1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	1.07e-05	0.000568	CbGpPWpGaD
Etoposide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	1.07e-05	0.000567	CbGpPWpGaD
Etoposide—PTGS1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.07e-05	0.000567	CbGpPWpGaD
Etoposide—PTGS1—Selenium Micronutrient Network—IL6—multiple sclerosis	1.07e-05	0.000566	CbGpPWpGaD
Etoposide—PTGS2—Selenium Micronutrient Network—TNF—multiple sclerosis	1.05e-05	0.000557	CbGpPWpGaD
Etoposide—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	1.05e-05	0.000556	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—GPC5—multiple sclerosis	1.04e-05	0.000552	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—RRM1—multiple sclerosis	1.02e-05	0.000539	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—SRM—multiple sclerosis	1e-05	0.000532	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—GPC5—multiple sclerosis	1e-05	0.00053	CbGpPWpGaD
Etoposide—GSTT1—Metabolism—ALB—multiple sclerosis	1e-05	0.00053	CbGpPWpGaD
Etoposide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	1e-05	0.00053	CbGpPWpGaD
Etoposide—CYP1A2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	1e-05	0.00053	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—RRM1—multiple sclerosis	9.81e-06	0.00052	CbGpPWpGaD
Etoposide—ABCC3—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	9.71e-06	0.000515	CbGpPWpGaD
Etoposide—PTGS2—Disease—GPC5—multiple sclerosis	9.49e-06	0.000503	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	9.45e-06	0.000501	CbGpPWpGaD
Etoposide—TOP2A—Circadian rythm related genes—IL6—multiple sclerosis	9.44e-06	0.0005	CbGpPWpGaD
Etoposide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	9.39e-06	0.000498	CbGpPWpGaD
Etoposide—CYP2C8—Biological oxidations—POMC—multiple sclerosis	9.3e-06	0.000493	CbGpPWpGaD
Etoposide—ABCC1—Disease—RPL5—multiple sclerosis	9.19e-06	0.000487	CbGpPWpGaD
Etoposide—PTGS2—Spinal Cord Injury—MYC—multiple sclerosis	8.93e-06	0.000473	CbGpPWpGaD
Etoposide—PTGS2—Spinal Cord Injury—TGFB1—multiple sclerosis	8.91e-06	0.000472	CbGpPWpGaD
Etoposide—ABCC1—Disease—SLC11A1—multiple sclerosis	8.8e-06	0.000466	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—SRM—multiple sclerosis	8.74e-06	0.000463	CbGpPWpGaD
Etoposide—PTGS2—Spinal Cord Injury—MAPK1—multiple sclerosis	8.73e-06	0.000463	CbGpPWpGaD
Etoposide—ABCB1—Allograft Rejection—TGFB1—multiple sclerosis	8.7e-06	0.000461	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—CYP24A1—multiple sclerosis	8.69e-06	0.00046	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—CYP27B1—multiple sclerosis	8.69e-06	0.00046	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—RRM1—multiple sclerosis	8.63e-06	0.000457	CbGpPWpGaD
Etoposide—PTGS2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	8.49e-06	0.00045	CbGpPWpGaD
Etoposide—PTGS2—Selenium Micronutrient Network—IL6—multiple sclerosis	8.49e-06	0.00045	CbGpPWpGaD
Etoposide—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	8.47e-06	0.000449	CbGpPWpGaD
Etoposide—ABCC3—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	8.34e-06	0.000442	CbGpPWpGaD
Etoposide—PTGS2—Spinal Cord Injury—TNF—multiple sclerosis	8.32e-06	0.000441	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—RRM1—multiple sclerosis	8.29e-06	0.000439	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—CYP27B1—multiple sclerosis	8.18e-06	0.000433	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—CYP24A1—multiple sclerosis	8.18e-06	0.000433	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—CYP27B1—multiple sclerosis	8.16e-06	0.000432	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—CYP24A1—multiple sclerosis	8.16e-06	0.000432	CbGpPWpGaD
Etoposide—ABCB1—Allograft Rejection—TNF—multiple sclerosis	8.13e-06	0.000431	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—GPC5—multiple sclerosis	7.94e-06	0.000421	CbGpPWpGaD
Etoposide—ABCC1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	7.61e-06	0.000403	CbGpPWpGaD
Etoposide—ABCC3—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	7.61e-06	0.000403	CbGpPWpGaD
Etoposide—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	7.49e-06	0.000397	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—GPC5—multiple sclerosis	7.48e-06	0.000396	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—GPC5—multiple sclerosis	7.46e-06	0.000395	CbGpPWpGaD
Etoposide—ABCC3—Transmembrane transport of small molecules—ALB—multiple sclerosis	7.23e-06	0.000383	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—BCHE—multiple sclerosis	7.19e-06	0.000381	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—CYP27B1—multiple sclerosis	7.07e-06	0.000375	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—CYP24A1—multiple sclerosis	7.07e-06	0.000375	CbGpPWpGaD
Etoposide—ABCC1—Disease—CD28—multiple sclerosis	7.03e-06	0.000372	CbGpPWpGaD
Etoposide—GSTP1—Metabolism—APOE—multiple sclerosis	7e-06	0.000371	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—SRM—multiple sclerosis	6.98e-06	0.00037	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	6.91e-06	0.000366	CbGpPWpGaD
Etoposide—PTGS2—Spinal Cord Injury—IL6—multiple sclerosis	6.71e-06	0.000356	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—RRM1—multiple sclerosis	6.58e-06	0.000349	CbGpPWpGaD
Etoposide—ABCC1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	6.54e-06	0.000346	CbGpPWpGaD
Etoposide—CYP1A2—Biological oxidations—POMC—multiple sclerosis	6.47e-06	0.000343	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—GPC5—multiple sclerosis	6.46e-06	0.000343	CbGpPWpGaD
Etoposide—PTGS1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	6.43e-06	0.000341	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle, Mitotic—MYC—multiple sclerosis	6.33e-06	0.000335	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—RRM1—multiple sclerosis	6.2e-06	0.000328	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle, Mitotic—MAPK1—multiple sclerosis	6.19e-06	0.000328	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—RRM1—multiple sclerosis	6.18e-06	0.000328	CbGpPWpGaD
Etoposide—PTGS2—Disease—RPL5—multiple sclerosis	6.17e-06	0.000327	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—CYP27B1—multiple sclerosis	6.16e-06	0.000326	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—CYP24A1—multiple sclerosis	6.16e-06	0.000326	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	6.07e-06	0.000322	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	6.06e-06	0.000321	CbGpPWpGaD
Etoposide—GSTP1—Metabolism—POMC—multiple sclerosis	6.01e-06	0.000319	CbGpPWpGaD
Etoposide—ABCC1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	5.96e-06	0.000316	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	5.94e-06	0.000315	CbGpPWpGaD
Etoposide—PTGS2—Disease—SLC11A1—multiple sclerosis	5.91e-06	0.000313	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—BCHE—multiple sclerosis	5.84e-06	0.00031	CbGpPWpGaD
Etoposide—ABCC2—Transmembrane transport of small molecules—ALB—multiple sclerosis	5.73e-06	0.000304	CbGpPWpGaD
Etoposide—ABCC1—Transmembrane transport of small molecules—ALB—multiple sclerosis	5.67e-06	0.0003	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle—MYC—multiple sclerosis	5.66e-06	0.0003	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	5.66e-06	0.0003	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—BCHE—multiple sclerosis	5.63e-06	0.000299	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—GPC5—multiple sclerosis	5.63e-06	0.000298	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle—MAPK1—multiple sclerosis	5.54e-06	0.000293	CbGpPWpGaD
Etoposide—PTGS1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	5.53e-06	0.000293	CbGpPWpGaD
Etoposide—GSTP1—Metabolism—ALB—multiple sclerosis	5.48e-06	0.000291	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—SRM—multiple sclerosis	5.38e-06	0.000285	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—RRM1—multiple sclerosis	5.36e-06	0.000284	CbGpPWpGaD
Etoposide—PTGS2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	5.11e-06	0.000271	CbGpPWpGaD
Etoposide—PTGS1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	5.04e-06	0.000267	CbGpPWpGaD
Etoposide—ABCC1—Disease—CD86—multiple sclerosis	5.02e-06	0.000266	CbGpPWpGaD
Etoposide—CYP3A4—Biological oxidations—POMC—multiple sclerosis	4.99e-06	0.000264	CbGpPWpGaD
Etoposide—ABCG2—Transmembrane transport of small molecules—ALB—multiple sclerosis	4.99e-06	0.000264	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—BCHE—multiple sclerosis	4.96e-06	0.000263	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	4.92e-06	0.00026	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	4.92e-06	0.00026	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	4.8e-06	0.000255	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—BCHE—multiple sclerosis	4.76e-06	0.000252	CbGpPWpGaD
Etoposide—PTGS2—Disease—CD28—multiple sclerosis	4.72e-06	0.00025	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—RRM1—multiple sclerosis	4.67e-06	0.000247	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—GPC5—multiple sclerosis	4.5e-06	0.000238	CbGpPWpGaD
Etoposide—ABCC1—Disease—CCR5—multiple sclerosis	4.45e-06	0.000236	CbGpPWpGaD
Etoposide—PTGS2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	4.39e-06	0.000232	CbGpPWpGaD
Etoposide—ABCC1—Disease—HLA-A—multiple sclerosis	4.33e-06	0.00023	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—APOE—multiple sclerosis	4.33e-06	0.000229	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	4.31e-06	0.000228	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	4.29e-06	0.000228	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	4.21e-06	0.000223	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	4.16e-06	0.00022	CbGpPWpGaD
Etoposide—ABCC1—Disease—APOE—multiple sclerosis	4.05e-06	0.000214	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	4.01e-06	0.000213	CbGpPWpGaD
Etoposide—PTGS2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	4e-06	0.000212	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	3.79e-06	0.000201	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	3.79e-06	0.000201	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—BCHE—multiple sclerosis	3.78e-06	0.0002	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—RRM1—multiple sclerosis	3.73e-06	0.000197	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—POMC—multiple sclerosis	3.72e-06	0.000197	CbGpPWpGaD
Etoposide—ABCC1—Disease—CD80—multiple sclerosis	3.66e-06	0.000194	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	3.57e-06	0.000189	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—BCHE—multiple sclerosis	3.56e-06	0.000189	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—BCHE—multiple sclerosis	3.55e-06	0.000188	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—APOE—multiple sclerosis	3.51e-06	0.000186	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—GPC5—multiple sclerosis	3.47e-06	0.000184	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—APOE—multiple sclerosis	3.39e-06	0.00018	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—ALB—multiple sclerosis	3.39e-06	0.00018	CbGpPWpGaD
Etoposide—PTGS2—Disease—CD86—multiple sclerosis	3.37e-06	0.000178	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	3.25e-06	0.000172	CbGpPWpGaD
Etoposide—ABCC1—Disease—TYK2—multiple sclerosis	3.09e-06	0.000164	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—BCHE—multiple sclerosis	3.08e-06	0.000163	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—POMC—multiple sclerosis	3.02e-06	0.00016	CbGpPWpGaD
Etoposide—PTGS2—Disease—CCR5—multiple sclerosis	2.99e-06	0.000158	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—APOE—multiple sclerosis	2.98e-06	0.000158	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—POMC—multiple sclerosis	2.91e-06	0.000154	CbGpPWpGaD
Etoposide—PTGS2—Disease—HLA-A—multiple sclerosis	2.91e-06	0.000154	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.89e-06	0.000153	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—RRM1—multiple sclerosis	2.87e-06	0.000152	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—APOE—multiple sclerosis	2.87e-06	0.000152	CbGpPWpGaD
Etoposide—ABCC1—Disease—CD4—multiple sclerosis	2.79e-06	0.000148	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—ALB—multiple sclerosis	2.75e-06	0.000146	CbGpPWpGaD
Etoposide—PTGS2—Disease—APOE—multiple sclerosis	2.72e-06	0.000144	CbGpPWpGaD
Etoposide—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.7e-06	0.000143	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—BCHE—multiple sclerosis	2.68e-06	0.000142	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—ALB—multiple sclerosis	2.65e-06	0.000141	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—POMC—multiple sclerosis	2.56e-06	0.000136	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.48e-06	0.000132	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—POMC—multiple sclerosis	2.46e-06	0.00013	CbGpPWpGaD
Etoposide—PTGS2—Disease—CD80—multiple sclerosis	2.46e-06	0.00013	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—ALB—multiple sclerosis	2.34e-06	0.000124	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—APOE—multiple sclerosis	2.27e-06	0.000121	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.26e-06	0.00012	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—ALB—multiple sclerosis	2.24e-06	0.000119	CbGpPWpGaD
Etoposide—ABCC1—Disease—STAT3—multiple sclerosis	2.16e-06	0.000115	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—APOE—multiple sclerosis	2.14e-06	0.000113	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—BCHE—multiple sclerosis	2.14e-06	0.000113	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—APOE—multiple sclerosis	2.14e-06	0.000113	CbGpPWpGaD
Etoposide—PTGS2—Disease—TYK2—multiple sclerosis	2.07e-06	0.00011	CbGpPWpGaD
Etoposide—ABCC1—Disease—MYC—multiple sclerosis	2.01e-06	0.000106	CbGpPWpGaD
Etoposide—ABCC1—Disease—TGFB1—multiple sclerosis	2e-06	0.000106	CbGpPWpGaD
Etoposide—ABCC1—Disease—MAPK1—multiple sclerosis	1.97e-06	0.000104	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—POMC—multiple sclerosis	1.95e-06	0.000104	CbGpPWpGaD
Etoposide—PTGS2—Disease—CD4—multiple sclerosis	1.87e-06	9.93e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—APOE—multiple sclerosis	1.85e-06	9.81e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—POMC—multiple sclerosis	1.84e-06	9.75e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—POMC—multiple sclerosis	1.84e-06	9.73e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—ALB—multiple sclerosis	1.78e-06	9.44e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—ALB—multiple sclerosis	1.68e-06	8.89e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—ALB—multiple sclerosis	1.67e-06	8.87e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—BCHE—multiple sclerosis	1.65e-06	8.75e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—APOE—multiple sclerosis	1.61e-06	8.54e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—POMC—multiple sclerosis	1.59e-06	8.42e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—IL6—multiple sclerosis	1.51e-06	8e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—STAT3—multiple sclerosis	1.45e-06	7.69e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—ALB—multiple sclerosis	1.45e-06	7.68e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—POMC—multiple sclerosis	1.39e-06	7.34e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—MYC—multiple sclerosis	1.35e-06	7.15e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—TGFB1—multiple sclerosis	1.35e-06	7.13e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—MAPK1—multiple sclerosis	1.32e-06	6.99e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—APOE—multiple sclerosis	1.29e-06	6.82e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—ALB—multiple sclerosis	1.26e-06	6.69e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—POMC—multiple sclerosis	1.11e-06	5.86e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—IL6—multiple sclerosis	1.01e-06	5.37e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—ALB—multiple sclerosis	1.01e-06	5.34e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—APOE—multiple sclerosis	9.93e-07	5.26e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—POMC—multiple sclerosis	8.53e-07	4.52e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—ALB—multiple sclerosis	7.78e-07	4.12e-05	CbGpPWpGaD
